S Trademark

Trademark Overview


On Friday, January 7, 2022, a trademark application was filed for S with the United States Patent and Trademark Office. The USPTO has given the S trademark a serial number of 97207472. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, September 9, 2024. This trademark is owned by Editas Medicine, Inc.. The S trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical use; cell components for medical use, namely, protein RNA complexes for medical use; cell components for medical use, namely, DNA and RNA for medical use; cell components for medical use, namely, DNA and RNA vectors for medical use; cell components for medical use, namely, DNA and RNA plasmids for medical use

Pharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Medical laboratory services in the nature of gene editing for developing cells and protein RNA complexes for medical use
s

General Information


Serial Number97207472
Word MarkS
Filing DateFriday, January 7, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements


Description of MarkThe mark consists of a stylized double helix design which incorporates a stylized letter "S".
Goods and ServicesCells for medical use; cell components for medical use, namely, protein RNA complexes for medical use; cell components for medical use, namely, DNA and RNA for medical use; cell components for medical use, namely, DNA and RNA vectors for medical use; cell components for medical use, namely, DNA and RNA plasmids for medical use
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Medical laboratory services in the nature of gene editing for developing cells and protein RNA complexes for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 13, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 13, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEditas Medicine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Party NameEditas Medicine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Trademark Events


Event DateEvent Description
Tuesday, January 11, 2022NEW APPLICATION ENTERED
Thursday, January 13, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 14, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, July 20, 2022ASSIGNED TO EXAMINER
Monday, July 25, 2022NON-FINAL ACTION WRITTEN
Monday, July 25, 2022NON-FINAL ACTION E-MAILED
Monday, July 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 13, 2024SOU EXTENSION 2 FILED
Friday, July 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 14, 2023SOU EXTENSION 1 FILED
Friday, July 14, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 13, 2024SOU EXTENSION 2 GRANTED
Monday, September 9, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2024SOU EXTENSION 3 FILED
Monday, September 9, 2024SOU EXTENSION 3 GRANTED
Thursday, March 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED